Suspension from Quotation
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Microba Life Sciences Limited has requested a voluntary suspension of its quoted securities, effective immediately, pending an announcement regarding a proposed merger. The suspension is due to concerns about the company's financial capacity to complete the merger and its cashflow position. Microba expects the suspension to last until the earlier of a specified date or the release of the relevant announcement to the market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
The securities of Microba Life Sciences Limited (‘MAP’) will be suspended from quotation immediately under Listing Rule 17.2 at the request of MAP, pending the release of an announcement by MAP. Unless ASX decides otherwise, the securities will remain suspended until the earlier of: • the end of the period stated in MAP’s request for voluntary suspension; or • the release of the announcement to th
Microba Life Sciences Limited on 6ix
Earlier from Microba Life Sciences
- TOV: GSS - Panel Receives Application
- Trading Halt Request
- Trading Halt
- Pause in Trading
- Cleansing Notice
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences